v3.26.1
Business Combinations and Contingent Consideration Liabilities - Schedule of Fair Value of Contingent Consideration Liability (Details) - Insight Genetics Inc [Member]
$ in Thousands
Dec. 31, 2025
USD ($)
Business Combination [Line Items]  
Contractual Value $ 6,000
Fair Value on the Merger Date 11,130
Milestone 1 [Member]  
Business Combination [Line Items]  
Contractual Value 1,500 [1],[2]
Fair Value on the Merger Date 1,340 [1],[2]
Milestone 2 [Member]  
Business Combination [Line Items]  
Contractual Value 3,000 [2]
Fair Value on the Merger Date 1,830 [2]
Milestone 3 [Member]  
Business Combination [Line Items]  
Contractual Value 1,500 [2]
Fair Value on the Merger Date 770 [2]
Royalty 1 [Member]  
Business Combination [Line Items]  
Fair Value on the Merger Date 5,980 [3]
Royalty 2 [Member]  
Business Combination [Line Items]  
Fair Value on the Merger Date $ 1,210 [1],[3]
[1] Contingent consideration is currently not expected to be paid out.
[2] Indicates the maximum amount payable if the Milestone is achieved.
[3] As defined, Royalty Payments are based on a percentage of future revenues of DetermaIO and Laboratory Services over their respective useful life, accordingly there is no fixed contractual value for the Royalty Contingent Consideration.